Search

Two‐dimensional (2D) cancer models have been the standard for drug development over the past few years, but they frequently do not resemble in vivo properties adequately. 3D models are superior in many aspects and are, therefore, more similar to human pathophysiology. Over the past years, the emerging field of biofabrication has made significant advances, resulting in even more sophisticated 3D models. With this study, a hydrogel is created for biofabrication that is suitable for mimicking the tumor microenvironment in vitro and is further tested as a new vascularized melanoma model in vivo. The alginate/hyaluronic acid/gelatin bioink shows good shape‐fidelity, high cell survival rates, and enables successful cultivation of melanoma cells and adipose‐derived stem cells as well as cell differentiation in vitro. In vivo, in the arteriovenous loop model, it proves to be a unique method to study melanoma progression, tumor vascularization, and ultimately and reliably metastases in an isolated and controlled environment. These results show that this 3D model is very application‐oriented for molecular research and therapy development. [ABSTRACT FROM AUTHOR]

Gelatin methacryloyl (GelMA)-based hydrogels have become highly studied as modular tissue culture platforms due to the combination of the bioactivity of gelatin and tailorability of photo-crosslinkable hydrogels. However, current production and characterization workflows still rely on manual, time-consuming, and low-throughput processes, ultimately limiting widespread adaption. To address these challenges, an open-source technology platform is engineered and validated for automated high-throughput production of GelMA-based 3D constructs by integrating automated pipetting capabilities for viscous and non-viscous liquids. Firstly, the platform is applied in combination with inexpensive absorbance measurements to systematically optimize the mixing sequence for GelMA-based precursor solutions. This enables a decrease in the relative standard deviation of the prepared mixtures from 63% to 2.5%, demonstrating a significantly improved reproducibility. Next, the applicability and high-throughput capacity are demonstrated by the reproducible generation of GelMA dilution series with 0.5 and 2% (w / v) concentration steps as well as double network hydrogels consisting of 2% (w / v) alginate and 5% (w / v) GelMA. Finally, a simple and user-friendly methodology is described that integrates Design of Experiments approaches to systematically study the combinatorial effects of material and crosslinking parameters and to establish a parameter library for on-demand production of mechanically defined GelMA-based hydrogels. The platform enables reproducible production and offers an open-source and accessible alternative to high-priced liquid-handling robots and bioprinters. [Display omitted] • Open-source platform overcomes manual and time-consuming processes for gelatin methacryloyl (GelMA)-based hydrogels • High-throughput production with automated workflows yields substantial increase in reproducibility compared to manual tasks • Materials library enables automatically production of mechanically defined 3D constructs with known parameters • Platform offers an open-source and accessible alternative to high-priced liquid-handling robots and bioprinters [ABSTRACT FROM AUTHOR]